Home/Filings/4/0001804567-25-000004
4//SEC Filing

Mottola Frank 4

Accession 0001804567-25-000004

CIK 0001356576other

Filed

Aug 26, 8:00 PM ET

Accepted

Aug 27, 4:59 PM ET

Size

8.6 KB

Accession

0001804567-25-000004

Insider Transaction Report

Form 4
Period: 2025-08-25
Mottola Frank
SVP, Quality, GMP, Ops, IT
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-08-2514,0000 total
    Exercise: $12.98Exp: 2026-03-01Common Stock (14,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-25$12.98/sh+14,000$181,72029,496 total
  • Sale

    Common Stock

    2025-08-25$44.51/sh14,000$623,14015,496 total
Footnotes (3)
  • [F1]Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
  • [F2]The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026.
  • [F3]The option vests in four equal annual installments beginning on March 1, 2017.

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1
  • filerCIK 0001804567

Filing Metadata

Form type
4
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 4:59 PM ET
Size
8.6 KB